ArticleEuropean journal of medical research2025
Machine learning clustering of carotid body tumor patients by clinical features and surgical approaches.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo classify CBT patients using machine learning-based clustering analysis to identify subgroups with different risks of complications and outcomes.
methodsThis retrospective, dual-center study included 127 patients who underwent CBT resection between 2003 and 2019. Clinical data were collected. Clustering analysis was performed using the Gower distance and silhouette coefficient to determine the optimal number of clusters. Clinical characteristics and outcomes were compared between phenotypes.
resultsPhenotype 1 (n = 29) consisted of patients who received preoperative embolization therapy, with a Shamblin III classification in 55.2% of cases and the shortest operative time (110 min). Phenotype 2 (n = 46) included patients with high-grade Shamblin classification without embolization therapy, characterized by longer operative times (240 min) and higher rates of vascular reconstruction (58.7%). Phenotype 3 (n = 52) comprised mainly female patients (80.8%) with Shamblin I tumors (51.9%) and the smallest tumor diameter (3 mm). Phenotype 2 had significantly higher estimated blood loss, postoperative stay, and cranial nerve injury rates compared to other phenotypes.
conclusionsPatients in Phenotype 2, with large tumors and high Shamblin classifications, had higher complication rates. Preoperative embolization combined with surgical resection was associated with lower surgical risks in these high-risk patients. This approach may provide a more precise method for identifying high-risk patients and could guide clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.